127 related articles for article (PubMed ID: 8101212)
1. GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
Dalia A; Neff NH; Hadjiconstantinou M
J Neurosci; 1993 Jul; 13(7):3104-11. PubMed ID: 8101212
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mesencephalic cultures after MPP+: the consequences of treatment with GM1 ganglioside.
Dalia A; Neff NH; Hadjiconstantinou M
Brain Res; 1996 Dec; 742(1-2):260-4. PubMed ID: 9117403
[TBL] [Abstract][Full Text] [Related]
3. GM1 ganglioside partially rescues cultured dopaminergic neurons from MPP(+)-induced damage: dependence on initial damage and time of treatment.
Stull ND; Schneider JS; Iacovitti L
Brain Res; 1994 Mar; 640(1-2):308-15. PubMed ID: 7911728
[TBL] [Abstract][Full Text] [Related]
4. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
Park TH; Mytilineou C
Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
[TBL] [Abstract][Full Text] [Related]
5. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
[TBL] [Abstract][Full Text] [Related]
6. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ
J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530
[TBL] [Abstract][Full Text] [Related]
7. Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside.
Goettl VM; Wemlinger TA; Fong TG; Neff NH; Hadjiconstantinou M
Brain Res; 2000 Sep; 877(1):1-6. PubMed ID: 10980236
[TBL] [Abstract][Full Text] [Related]
8. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
10. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
11. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence.
Sanchez-Ramos JR; Michel P; Weiner WJ; Hefti F
J Neurochem; 1988 Jun; 50(6):1934-44. PubMed ID: 2897430
[TBL] [Abstract][Full Text] [Related]
12. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
Mena MA; Casarejos MJ; García de Yébenes J
J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
[TBL] [Abstract][Full Text] [Related]
13. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
14. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
Michel PP; Agid Y
Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.
Sautter J; Höglinger GU; Oertel WH; Earl CD
Exp Neurol; 2000 Jul; 164(1):121-9. PubMed ID: 10877922
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
[TBL] [Abstract][Full Text] [Related]
17. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
Otto D; Unsicker K
J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.
Hou JG; Lin LF; Mytilineou C
J Neurochem; 1996 Jan; 66(1):74-82. PubMed ID: 8522992
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
Michel PP; Dandapani BK; Knusel B; Sanchez-Ramos J; Hefti F
J Neurochem; 1990 Apr; 54(4):1102-9. PubMed ID: 1968953
[TBL] [Abstract][Full Text] [Related]
20. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells.
Church WH; Hewett SJ
J Neurosci Res; 2003 Sep; 73(6):811-7. PubMed ID: 12949907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
